External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

IDW 2023

-
Coming soon
04:15 PM
Duration 1hr Boston, USA
Development of a Prototype Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus complex (CRABC) Assay for use on the cobas 5800/6800/8800 System Utility Channel
Sorenson NM, Nguyen H, Moghaddasi A, Sathish A, Somanathan I, Jia L, Lin P, Zhuang X, Lam C, Lee BP, Cady KC

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 1hr Boston, USA
Household Flu Transmission and Healthcare Resource Use among Patients Treated with Baloxavir▼ versus Oseltamivir for Influenza: An Outpatient Prospective Survey in the United States
Best J, Sadeghi M, Sun X, Seetasith A, Albensi L, Joshi S, Zervos M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 1hr Boston, USA
Cost-effectiveness of baloxavir marboxil▼ vs oseltamivir or no treatment for the management of influenza in the United States
Kommandantvold S, Chang S, Surinach A, Yau V, Best J, Zaraket H, Zhou H Blanchet-Zumofen M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar